Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Galecto Biotech

Galecto Biotech

Galectin-targeting therapeutics

Overview Structured Data Issues Contributors Activity

Is a

Company attributes

Industry

Biopharmaceutical

Biomedical engineering

Location

0

CEO

Hans T. Schambye

0

Founder

0

0

0

Hans T. Schambye

0

Pitchbook URL

pitchbook.com/profiles.../56739-07

Legal Name

Galecto, Inc.

Number of Employees (Ranges)

11 – 50

Full Address

Ole Maaloes Vej 3 DK-2200 Copenhagen N Denmark0

Investors

Merck Serono Ventures (M Ventures)

0

Maverick Ventures

Bristol-Myers Squibb

Seventure Partners

HBM Healthcare Investments AG

...

Founded Date

January 1, 2011

Total Funding Amount (USD)

154,000,000

Latest Funding Round Date

September 29, 2020

Stock Symbol

GLTO0

Exchange

0

Latest Funding Type

Patents Assigned (Count)

14

Country

0

Other attributes

Company Operating Status

Active

Ticker Symbol

GLTO

Wikidata ID

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Galecto Biotech

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool